Monoclonal Antibody Sites in Florida to Temporarily Close Down After FDA Limits Use of Two Treatments; Shown to be Ineffective Against Omicron Variant
Sites for monoclonal antibody treatments will close temporarily after it was found that they don't work against Omicron variant.
